Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 8 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Sol-Gel Technologies Ltd. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q2 2023
- Shares held
- 8.04M
- +156.6K (+2.0%) vs. Q2 2023
- Total value
- $13.1M
- −$10.5M (−44.3%) vs. Q2 2023
- New holders
- 2
- 2 more added
- Sold out
- 1
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $98.1M |
| Q1 2026 | 21 | $100.0M |
| Q4 2025 | 14 | $30.2M |
| Q3 2025 | 10 | $16.3M |
| Q2 2025 | 11 | $4.87M |
| Q1 2025 | 21 | $2.76M |
| Q4 2024 | 17 | $4.86M |
| Q3 2024 | 20 | $3.67M |
| Q2 2024 | 20 | $6.56M |
| Q1 2024 | 20 | $7.64M |
| Q4 2023 | 21 | $9.94M |
| Q3 2023 | 18 | $17.7M |
| Q2 2023 | 17 | $23.6M |
| Q1 2023 | 15 | $31.3M |
| Q4 2022 | 14 | $26.0M |
| Q3 2022 | 13 | $29.5M |
| Q2 2022 | 17 | $23.7M |
| Q1 2022 | 17 | $42.9M |
| Q4 2021 | 18 | $43.5M |
| Q3 2021 | 18 | $58.7M |
| Q2 2021 | 16 | $72.6M |
| Q1 2021 | 20 | $71.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Sol-Gel Technologies Ltd.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Phoenix Holdings Ltd. | 2,574,922 | $4.20M | 0.08% | 00.0% | Unchanged |
| Armistice Capital, LLC | 2,135,000 | $3.48M | 0.10% | −73,000−3.3% | Reduced |
| Migdal Insurance & Financial Holdings Ltd. | 1,230,636 | $2.01M | 0.04% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 920,333 | $1.50M | 0.03% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 766,858 | $1.25M | 0.23% | −4,107−0.5% | Reduced |
| Yelin Lapidot Holdings Management Ltd. | 229,178 | $387.3K | 0.10% | +229,178 | New |
| Raymond James Financial Services Advisors, Inc. | 55,112 | $89.8K | 0.00% | +932+1.7% | Added |
| Raymond James & Associates | 35,461 | $57.8K | 0.00% | −533−1.5% | Reduced |
| Morgan Stanley | 29,235 | $47.7K | 0.00% | −3,656−11.1% | Reduced |
| Invesco Ltd. | 13,632 | $22.2K | 0.00% | +13,632 | New |
| Citadel Advisors LLC | 13,443 | $21.9K | 0.00% | −4,311−24.3% | Reduced |
| Geode Capital Management, LLC | 13,406 | $21.9K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 6,500 | $10.6K | 0.00% | +1,033+18.9% | Added |
| Steward Partners Investment Advisory, LLC | 6,160 | $10.0K | 0.00% | −100−1.6% | Reduced |
| Allworth Financial LP | 5,380 | $8.77K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 3,089 | $5.04K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,497 | $4.07K | 0.00% | −1,995−44.4% | Reduced |
| Bank of America Corp | 100 | $163 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −458−100.0% | Sold out |